Are you a non-MD Pediatric Oncology/Hematology/BMT health care professionals working in Canada? Would $1000 enable your attending an educational conference or workshop? Then you need to apply for the C17 Norma Auger Education Fund (applications due 01 Nov 2017)

The goal of the C17 Norma Auger Education Fund is to support health professionals involved in pediatric Oncology/Hematology/BMT across Canada advance their knowledge, skills and experience and to promote presentations and knowledge translation by these health professionals.

This is an annual scholarship offered by the C17 Education Committee with funding from the Childhood Cancer Canada Foundation.
Eligibility:  Non-MD Pediatric Oncology/Hematology/BMT health care professionals working in Canada.

Application deadline: November 1, 2017.

Application forms can be downloaded HERE: Norma Auger Application Aug’17.


Help #KidsCancerPain by posting the attached flyer, and by sharing via the provided social media links. It could be worth $250 for one of your families and help combat kids cancer pain

Dear Friends and Colleagues:

We’d be so grateful if you could help us spread the word about our #KidsCancerPain post-campaign survey, which is only open for less than 2 more weeks (the last day is October 10th).  This is a critical component of the evaluation of our Canadian Cancer Society funded Knowledge to Action grant, and as of yesterday we have only had about 20 parents complete the survey, and we need 100.

If you know of a parent or caregiver of a child with cancer, who may have seen ANY of our #KidsCancerPain content over the past year….please have them complete our survey! They could win 1 of 3 VISA gift cards valued at $250 (CDN)!

The survey link is:

If you could please do any or all of the following:

  1. forwarding to applicable parents/caregivers
  2. Print and post the image/poster (below) where it will be seen by parents/caregivers.  Download the file KidsCancerPainImagewLink.
  3. Share this tweet:
  4. Share this Facebook post:
  5. Or create your own social media post using the survey link above and the attached image, along with our hashtag #KidsCancerPain


Thank you!

Christine, on behalf of the #KidsCancerPain team

LAST CHANCE for a free lunch and opportunities to publish!

CYP-C Research Champions will be meeting at SIOP in Washington DC on October 13 in the Capitol Room (1:30-5pm) at the Marriott Wardman Park.

The purposes will be to:

1) Provide an overview of CYP-C

2) Provide brief education related to how to measure socioeconomic status using census data (i.e. for CYP-C projects)

3) Begin to create publication teams – this will be an opportunity to be a co-investigator or to lead CYP-C publications

Contact by Oct 6 to attend.

C17 Research Network Call for Nominations: Clinical Research – Stem Cell Transplantation. Due 31-Oct-2017. Click for application/nomination instructions

The C17 Research Network Committee is seeking applications for the position of Clinical Research – Stem Cell Transplantation (1 position).

Applicants should have experience in basic and clinical research who have established reputations in their respective fields, and who share a national vision for research. They will have an affiliation with one of the 17 centres or associated universities. Consideration will also be given to selecting members who represent large and small centres, and institutions across Canada.

We ask all who receive this call for nominations to help us to distribute it as widely as possible. Please forward the call for nominations to institutions, organizations and individuals who might be interested in posting and/or responding to it. 

Application instructions can be found in the following document:  Call for nominations Sept 2017


23rd Annual Western Canada Nutrition Day – Optimizing Nutrition and Medicine in Cancer Care October 21, 2017 (Edmonton)

We are pleased to extend our personal invitation to the 23rd Annual Western Canada Nutrition Day Conference: Optimizing Nutrition and Medicine in Cancer Care.
The 23rd Annual Western Canada Nutrition Day – Optimizing Nutrition and Medicine in Cancer Care will include subject matter experts from Canada, Italy and Australia. The conference will feature discussions on the full spectrum of cancer care including: Sarcopenic Obesity and Cancer Care, the application of nutrients to modify toxicities of cancer treatment, ESPEN 2017, PN in Cancer Care, INFORM, what we know (and what we don’t) about diet and cancer prevention and much more!

Our audience for this event includes: Dietitians, physicians, nurses and allied healthcare professionals interested in learning more about nutrition and medicine in cancer care.

When: October 21, 2017
Where: Robbins Learning Centre – Royal Alexandra Hospital, 10240 Kingsway Avenue, Edmonton, AB T5H 3V9

Online Registration opens: August 23, 2017
Early bird deadline: October 6, 2017
Online registration:
Event code: 8NN28SBJHRD
Email address:

This event is planned by Alberta Health Services, and supported by an unrestricted grant from Nestle Health Science.

NEW C17 GRANT COMPETITION —The 100% Fund. Watch for a call for applications in the areas of infant ALL, rhabdomyosarcoma and Ewing sarcoma (click to read more!)

We are thrilled to announce a new C17 grant competition that will be run in addition to our regular C17 Operating Grant completion.  Watch for a call for Letters of Intent* this month!

Nearly one in five children diagnosed with cancer will not survive. For children with rare and hard to treat cancers, the odds can be far worse.

The 100% Fund has been created to challenge these odds. In recognition of its 30th anniversary, Childhood Cancer Canada (CCC) is proud to partner with organizations with a shared passion to help fund research for children who do not, yet, have their cure.   The list is growing, but confirmed organizations as of September 12th are:

By building on new and exciting research initiatives in Canada and around the world, The 100% Fund ( will pave the way for collaborative research into cutting-edge therapies for tumours that have not responded to currently available treatments.

CCC will partner with C17 Council and its C17 Research Network to administer the grants. As a national research organization representing leading pediatric oncology programs across Canada, the experts at the C17 know the priorities of children and their families that have been impacted by childhood cancer.

* Applications will include a full letter of intent with a 3 page research proposal.  Successful LOI will advance to the full grant application stage.  Applicants not funded in the funding round currently in progress will be able to submit to this upcoming competition.

JOB POSTING: Clinical Research Associate at BC Children’s (Research Asst/Tech 3; closing date Sept-30)

For a full job posting and details of duties, please see the posting at

The BC Children’s Hospital Division of Hematology/Oncology/Bone Marrow Transplant (Hem/Onc/BMT) and the Child and Family Research Institute, is looking for a Clinical Research Associate (Research Tech 3). The Research Technician (RT3) will report directly to the Clinical Trials Unit Manager (CTU Manager) who is under the supervision of the Division head and Research Director, respectively. The incumbent will also report to and receive direction from the Principal Investigator of each assigned project.

Work Performed: To coordinate clinical research protocols, including but not limited to Phases I, II and III chemotherapy studies, hematology studies, bone marrow transplant studies, supportive care studies and ancillary studies for Childhood Cancer and Blood Research.

  • Ensuring adherence to and maintenance of protocols
  • Maintaining protocols and associated documents to ensure they are up-to date
  • Responsible for the day-to-day operation of multi-site investigator initiated project
    Working closely with the clinical research staff
  • Identifying potential study participants
  • Reviewing and confirming eligibility criteria
  • Registration of patients on clinical studies
  • Creation of study specific documents
  • Accurate and timely completion and submission of paper and electronic data capture forms
  • Creating and maintaining research charts on registered subjects
  • Reporting adverse drug reactions in consultation with physician and in accordance with protocol-specific guidelines
  • Procuring and safely shipping as well as maintaining accurate documentation of study specimens from various sources according to protocol guidelines and federal regulations
  • Acting as liaison with health care team and laboratory team, both on-site and outside the institution, for project management and information exchange regarding clinical studies
  • Performing data entry and managing research databases with accuracy
  • Preparing and participating in audits and study monitoring visits from various regulatory bodies
  • Attending conferences and meetings, possibly involving travel
    Timely completion of required regulatory certificates and tutorials
  • Maintaining clinical research education and regulatory certifications
  • Providing back-up for other team members while sick or on holidays
  • If not already obtained, the division will support training for clinical research professional certification through the Society of Clinical Research Associates
  • Performing other related tasks and projects as deemed necessary

REGISTRATION NOW OPEN for the C17 Next Generation of Early Phase Trials: Moving the Bar in Pediatric Oncology workshop (04-Nov- 2017, pre-session meeting at CCRA conference in Vancouver)


C17 “Next Generation of Early Phase Trials: Moving the Bar in Pediatric Oncology” educational workshop will be held on Saturday, 4 November 2017 in Vancouver, BC. The workshop is in response to the C17 DVL needs assessment that was completed last year; members from all C17 DVL sites and PROFYLE clinical site leads are encouraged to attend.

The workshop is a full day, pre-session workshop at the CCRA Canadian Cancer Research Conference. We hope that most attendees at our workshop will take the opportunity to attend the full conference as well.

The workshop will be designed to educate investigators on traditional models of early phase trials as well as newer approaches to drug development. We will also cover regulatory, ethical, advocacy and access aspects of early phase trials. The workshop will proved education, discussions, panels and time for questions.

Travel and accommodation booking information will be emailed to you upon completion of the registration.



DUE NEXT WEEK ⇒ Registration for the C17 Operating and Ewing Sarcoma Grant Competition are due 08-Sep-17, 4 pm MDT. [Grants due 29-Sep-17]

The short registration form for the C17 Operating and Ewing Sarcoma Grant Competitions is due NEXT WEEK on 08-Sep-17 at 4 pm MDT (Edmonton). Early submission appreciated.

All applicants who submit a registration by the due date will automatically advance to the grant application stage. Grants are due on 29-Sep-17 (4 pm MDT).

Miss the original call?  You can find the call and forms at:


CHU Sainte-Justine Pediatric Hematology-Oncology Division, Department of Pediatrics, Université de Montréal, is seeking to recruit a clinician specialized in transfusion medicine for a position of Assistant or Associate Professor and Blood Bank Medical Director

The position of blood bank director at Ste-Justine will be soon vacant. Please circulate this job offer within your team, fellows or to anyone who might potentially be interested.
English posting follows French posting


Le service d’Hématologie -Oncologie Pédiatrique du CHU Sainte-Justine, Département de Pédiatrie de l’Université de Montréal, recherche un clinicien spécialiste en médecine transfusionnelle pour un poste de Professeur Assistant ou Agrégé de clinique et assurer la Direction Médicale de la Banque de Sang.

A côté d’une activité clinique à temps partiel en hématologie-oncologie pédiatrique et de la grossesse, les tâches sont essentiellement reliées à la médecine transfusionnelle :

  • Direction Médicale de la Banque de Sang du CHU, le plus important centre mère-enfant du Canada, et l’un des plus grands centres pédiatriques en Amérique du Nord.
  • Une activité de soins cliniques majoritairement en relation avec la médecine transfusionnelle.
  • Une activité de recherche en hématologie et médecine transfusionnelle.
  • Le titulaire devra s’impliquer activement dans l’enseignement de la médecine transfusionnelle. Le service d’hématologie et oncologie du CHU Sainte-Justine est membre du Département de Pédiatrie de l’Université de Montréal et son programme de formation en Hémato-Oncologie Pédiatrique est accrédité par le Collège Royal des Médecins et Chirurgiens du Canada (CRMCC).

Le poste est un poste provincial (PEM) en médecine transfusionnelle et le titulaire devra consacrer 80% de sa pratique professionnelle à des activités (laboratoire, clinique, gestion, recherche) en relation avec la médecine transfusionnelle. Un rayonnement provincial, national et rapidement international est attendu.

Les personnes intéressées doivent avoir un diplôme de docteur en médecine, avoir complété une formation complémentaire en médecine transfusionnelle (certificat de médecine transfusionnelle du CRMCC ou équivalent), faire preuve de leadership et avoir un fort esprit d’équipe. Une formation spécialisée en hématologie-oncologie pédiatrique n’est pas requise pour appliquer à ce poste, mais sera considéré comme un atout important.

La maîtrise de la langue française est nécessaire aux activités cliniques et de gestion.


Les candidatures seront étudiées attentivement, même si le candidat n’est pas disponible pour les prochains mois. Les candidatures ayant besoin d’une formation complémentaire seront également étudiées attentivement.


Les personnes intéressées peuvent prendre contact avec l’un des co-chefs de service d’hématologie-oncologie du CHU Sainte-Justine :

Yves Pastore ,


Michel Duval,

CHU Sainte-Justine
Service d’hématologie et centre de cancérologie Charles-Bruneau
3175 Côte Sainte-Catherine
Montréal (QC) H3T1C5
Tel : 514 v345 4931, poste 4870
Ou 514-345-4639

The CHU Sainte-Justine Pediatric Hematology-Oncology Division, Department of Pediatrics, Université de Montréal, is seeking to recruit a clinician specialized in transfusion medicine for a position of Assistant or Associate Professor and Blood Bank Medical Director.
In addition to a part-time clinical care activity in Hemato-Oncology in children and pregnant women, most of the time will be devoted to activities related to transfusion medicine:

  • Direction of the Blood Bank at CHU Sainte-Justine, the largest mother-child hospital in Canada.
  • Research in transfusion medicine. A leading participation in research and expert committees are expected at the provincial, national and international level.
  • Teaching in transfusion medicine. The hemato-oncology division is a member of the Department of Pediatrics of Université de Montréal, and its program is accredited by the Royal College of Physicians and Surgeons of Canada. has a fully accredited Pediatric Hematology/Oncology subspecialty-training program through the Royal College of Physicians and Surgeons of Canada. The division is active in teaching at the undergraduate and postgraduate levels, and It is in particular expected that the
    applicant will lead education on specific aspects related to transfusion medicine.


It is the provincial position (PEM) in pediatric transfusion medicine, and the holder must devote 80 % of his professional practice (laboratory, clinic, research, management) to transfusion medicine. A provincial, national and soon international influence is expected.

Interested applicants, including clinician-investigators and clinician-scientists, must hold an MD and must have completed a full training in transfusion medicine (certificate of transfusion medicine of the RCPSC or equivalent), have strong leadership capability, and a good team spirit; a specialization in pediatric hematologyoncology is not required but will considered a strong asset.

Working knowledge of French language is needed for the clinical and administrative activities.

Please contact one of the Division co-chairs :

Yves Pastore,


Michel Duval,

CHU Sainte-Justine
Hematology service and Charles Bruneau Cancer Center
3175 Côte Sainte-Catherine
Montréal (QC) H3T1C5
Tel : 514 v345 4931, poste 4870
Or 514-345-4639

Le CHU Sainte-Justine est un hôpital universitaire mère-enfant de 500 lits, assurant les soins tertiaires et quaternaires pour l’ensemble de la Province du Québec (7.8 millions d’habitants). L’agrandissement important du centre de cancérologie Charles- Bruneau et la désignation comme un des axes de développement prioritaire pour le CHU s’accompagne d’une nouvelle ambition pour le service d’Hématologie-Oncologie. Le service compte 14 hématologues-oncologues pédiatriques, et vise à court terme à engager 3 médecins supplémentaires. Plus de 140 nouveaux patients atteints de leucémie ou cancer sont pris en charge chaque année. Le centre de jour reçoit plus de 15,000 visites par année, et l’unité d’hospitalisation dispose de 32 lits. Le programme de transplantation hématopoïétique (50 transplantations par année) est accrédité FACT et dispose d’une unité de 12 lits. Les activités incluent également l’hématologie générale, les anémies falciformes avec plus de 350 patients suivis, l’hémophilie avec plus de 250 patients suivis et un programme d’aphérèse avec plus de 250 procédures par année. Le service comporte de plus des laboratoires de diagnostic de pointe en hématologie-cytologie, hémostase et thrombose. Intégrés au service, le laboratoire de thérapie cellulaire soutien le programme clinique de greffe, et la banque de sang assure l’ensemble des transfusions du CHU. Le service conduit une intense activité de recherche fondamentale, translationnelle et clinique, notamment en hématologie et en médecine

Situé dans une très active métropole multiculturelle de 3.7 millions d’habitants, le CHU Sainte-Justine et son Centre de Recherche sont situés à proximité immédiate du campus universitaire de l’Université de Montréal. Cet environnement de recherche profite de la richesse du milieu académique montréalais et de la collaboration de groupe de recherche de la Province de Québec.

Les candidats travailleront dans un groupe très intégré de chercheurs cliniciens et fondamentaux, qui encourage les approches multidisciplinaires et la recherche translationnelle. Plus de 20 équipes de recherche d’horizons variés collaborent à des projets de recherche fondamentale et translationnelles, avec trois pôles principaux : oncogénetique et étiologie des cancers (incluant une forte activité de pharmacologie et pharmacogénomique), greffe de sang de cordon et immunologie du sang de cordon, qualité de vie.

Une unité de recherche clinique très active, reconnue par des agréments d’organisations internationale (Children Oncology Group, Dana Farber Consortium, Pediatric Blood and Marrow Transplantaion Consortium) regroupe 10 infirmières ou assistantes de recherche clinique et maintient ouverts plus de 100 protocoles de recherche multicentriques en oncologie pédiatrique et en transplantation. Elle est la seule unité de recherche clinique du Québec offrant l’inclusion à des essais de Phase I et Phase II aux enfants atteints de cancer.

Le programme d’enseignement de l’hématologie-oncologie pédiatrique est agréé par le Collège Royal des Médecins du Canada. Ce programme de formation est reconnu internationalement, comme en témoigne la présence permanente de quatre moniteurs cliniques (fellows) venant de l’extérieur du Québec.